Tarestumab OMP 59R5 represents a compelling clinical agent targeting Notch-2 , a important protein implicated in various hematologic disorders . This genetically engineered immunoglobulin selectively https://caoimheutxu639251.activoblog.com/53222890/tarestumab-omp-59r5-a-innovative-anti-notch2-immunoglobulin